Product Recalls in Vermont

Product recalls affecting Vermont — including food, drugs, consumer products, medical devices, and vehicles distributed to Vermont. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,521 recalls have been distributed to Vermont in the last 12 months.

47,027 total recalls
2,521 in last 12 months

Showing 46414660 of 13,356 recalls

DrugMarch 2, 2020· Noven Therapeutics, LLC

Recalled Item: Daytrana (methylphenidate transdermal system) patches Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for mechanical peel and shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2020· Noven Therapeutics, LLC

Recalled Item: Daytrana (methylphenidate transdermal system) patches Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for mechanical peel and shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2020· Mayne Pharma Inc

Recalled Item: Carbidopa and Levodopa Tablets Recalled by Mayne Pharma Inc Due to Product...

The Issue: Product Mix-Up: A foreign tablet was found in bottle.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2020· Noven Therapeutics, LLC

Recalled Item: Daytrana (methylphenidate transdermal system) patches Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for mechanical peel and shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 2, 2020· Noven Therapeutics, LLC

Recalled Item: Daytrana (methylphenidate transdermal system) patches Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for mechanical peel and shear.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 27, 2020· The Harvard Drug Group

Recalled Item: Quetiapine Fumarate Extended-Release Tablets Recalled by The Harvard Drug...

The Issue: Labeling; Incorrect or Missing Package Insert: Product was packaged with the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 27, 2020· Pfizer Inc.

Recalled Item: Elelyso (taliglucerase alfa) for injection Recalled by Pfizer Inc. Due to...

The Issue: Lack of Assurance of Sterility--Reports of loose metal ferrule crimps on...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 27, 2020· The Harvard Drug Group

Recalled Item: Quetiapine Fumarate Extended-Release Tablets Recalled by The Harvard Drug...

The Issue: Labeling; Incorrect or Missing Package Insert: Product was packaged with the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 27, 2020· The Harvard Drug Group

Recalled Item: Quetiapine Fumarate Extended-Release Tablets Recalled by The Harvard Drug...

The Issue: Labeling; Incorrect or Missing Package Insert: Product was packaged with the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 27, 2020· The Harvard Drug Group

Recalled Item: Quetiapine Fumarate Extended-Release Tablets Recalled by The Harvard Drug...

The Issue: Labeling; Incorrect or Missing Package Insert: Product was packaged with the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 24, 2020· Breckenridge Pharmaceutical, Inc

Recalled Item: Zoledronic Acid Injection 5 mg/100 mL (0.05 mg/mL) Recalled by Breckenridge...

The Issue: Failed Impurities/Degradation Specifications: Out-of-specification results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 21, 2020· Akorn, Inc.

Recalled Item: Well at Walgreens Sodium Chloride Ophthalmic Ointment USP Recalled by Akorn,...

The Issue: Presence of Particulate Matter: Brown spots observed on the inside of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 21, 2020· Akorn, Inc.

Recalled Item: CVS Health Sodium Chloride Ophthalmic Ointment USP Recalled by Akorn, Inc....

The Issue: Presence of Particulate Matter: Brown spots observed on the inside of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 21, 2020· Akorn, Inc.

Recalled Item: Sodium Chloride Ophthalmic Ointment USP Recalled by Akorn, Inc. Due to...

The Issue: Presence of Particulate Matter: Brown spots observed on the inside of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 20, 2020· Teva Pharmaceuticals USA

Recalled Item: Mesalamine Delayed-Release Tablets Recalled by Teva Pharmaceuticals USA Due...

The Issue: Failed Dissolution Specifications: Low out of specification dissolution...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 17, 2020· Strides Pharma Science Limited

Recalled Item: Potassium Chloride Extended-Release Tablets USP Recalled by Strides Pharma...

The Issue: Failed Tablet/Capsules Specifications: Oversized tablets were found in one...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 12, 2020· Golden State Medical Supply Inc.

Recalled Item: TRAMADOL HYDROCHLORIDE Tablets Recalled by Golden State Medical Supply Inc....

The Issue: Labeling: Incorrect package insert - Patient leaflets for the specified lots...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 12, 2020· Lupin Pharmaceuticals Inc.

Recalled Item: Memantine Hydrochloride Extended Release Capsules Recalled by Lupin...

The Issue: Failed Dissolution Specifications: Low out of specification results observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 10, 2020· Par Pharmaceutical Inc.

Recalled Item: Frovatriptan Succinate Tablets Recalled by Par Pharmaceutical Inc. Due to...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 7, 2020· AuroMedics Pharma LLC

Recalled Item: Amoxicillin and Clavulanate Potassium Tablets Recalled by AuroMedics Pharma...

The Issue: Presence of Foreign Substance: Customer complaint of a foreign substance...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund